|

BCA101 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Ficerafusp alfa

Pipeline

Phase 1: 1

Top Sponsors

  • Bicara Therapeutics1

Indications

  • Carcinoma, Squamous Cell1
  • EGFR Amplification1
  • Squamous Cell Carcinoma of Anal Canal1
  • Squamous Cell Carcinoma of the Lung1
  • Squamous Cell Carcinoma of Head and Neck1

La Jolla, California1 trial

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Moores Cancer Center UC San Diego Health

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.